Obstetrics & Gynecology Doctors in Bryan, OH Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Hanan Ghossein Bazzi, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 433 W High St, Bryan, OH 43506 Phone: 419-636-1131    Fax: 419-636-3100

Adnan A. Al-khaleefa, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 442 W High St, Bryan, OH 43506 Phone: 419-636-4517    Fax: 419-636-6438

Mohamed A El Nemr, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 442 W High St Ste 3, Bryan, OH 43506 Phone: 419-636-4517

Almario R. Tantoco, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 442 W High St, Bryan, OH 43506 Phone: 419-636-4517    Fax: 419-636-6438

Sharon A. Ransom, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 442 W High St, Bryan, OH 43506 Phone: 419-636-4517    Fax: 419-636-6438

News Archive

Advance Study to evaluate safety and benefit of DBS-f for patients with mild Alzheimer's

The first U.S. patient to enroll in Functional Neuromodulation's ADvance Study was successfully implanted with a deep brain stimulation (DBS) system. ADvance will evaluate the safety and potential clinical benefit of DBS of the fornix (DBS-f), a major inflow and output pathway in the brain's memory circuit, for patients with mild Alzheimer's.

Study: Low BP levels are unhealthy for CKD patients

Recent guidelines by The National Kidney Foundation Disease Outcomes Quality Initiative (NKF KDOQI)1 call for lower target blood pressure levels in patients with chronic kidney disease (CKD).

FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence

Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence.

China SFDA approves Veridex's CellSearch test for women with metastatic breast cancer

Veridex, LLC today announced approval from the China State Food & Drug Administration (SFDA) for the CellSearch circulating tumor cell (CTC) test as an in vitro diagnostic for women with metastatic breast cancer.

FAU researchers receive NSF grant to model COVID-19 spread using big data analytics

Public health efforts depend heavily on predicting how diseases like COVID-19 spread across the globe. Researchers from Florida Atlantic University's College of Engineering and Computer Science in collaboration with LexisNexis Risk(R)Solutions, a global data technology and advanced analytics leader, have received a rapid research (RAPID) grant from the National Science Foundation to develop a model of COVID-19 spread using innovative big data analytics techniques and tools.

Read more Medical News

› Verified 1 days ago